Skip to main content
SpringerLink
Log in

The Development and Psychometric Properties of the MSQOL

A Migraine-Specific Quality-of-Life Instrument

  • Clinical Pharmacoeconomic
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Summary

This paper describes the development and testing of the UK version of the Migraine-Specific Quality-of-Life instrument (MSQOL), a measure designed to assess the quality of life of migraineurs. The work was part of an international research study conducted in eight countries, with the initial development work conducted in the UK and the USA. In the UK, interviews were held with 30 patients with migraine, while in the USA, 25 individual interviews were conducted, along with one focus group with 5 participants. Transcripts were produced of the interviews/group discussion and these were used to determine the questionnaire items, which were then considered by an international translation panel. The panel considered the feasibility of translating the items into other European languages. The instrument was then assessed for reliability and validity. The UK version of the MSQOL was shown to have excellent testretest reliability (0.93 over 2 weeks) and internal consistency (0.92 and 0.93 on the first and second administrations, respectively). Scores on the measure were also found to be related to a comparator measure of well-being and to perceived severity of migraine and disruption caused to patients by the disease. Findings for the other language versions of the MSQOL supported those from the UK, suggesting that the instrument may well be suitable for inclusion in clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Isler H. Retrospect: the history of thought about migraine from Aretaeus to 1920. In: Blau JN, editor. Migraine. London: Chapman and Hall, 1987

    Google Scholar 

  2. International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(7 Suppl.): 19–28

    Google Scholar 

  3. Newland CA, Illis LS, Robinson PK, et al. A survey of headache in an English city. Res Clin Stud Headache 1978; 5: 1–20

    PubMed  CAS  Google Scholar 

  4. Fry J. Profiles of disease. Edinburgh: Livingstone, 1966

    Google Scholar 

  5. Green JE. A survey of migraine in England 1975–1976. Headache 1977; 17: 67–8

    Article  PubMed  Google Scholar 

  6. Osterhaus JT, Gutterman DL, Plachetka JR. Healthcare resource and lost labour costs of migraine headaches in the US. PharmacoEconomics 1992; 2: 67–76

    Article  PubMed  CAS  Google Scholar 

  7. Blau JN. Fears aroused in patients by migraine. BMJ 1984; 288: 1126

    Article  PubMed  CAS  Google Scholar 

  8. Breslau N, Andreski P. Migraine, personality and psychiatric comorbidity. Headache 1995; 35: 382–6

    Article  PubMed  CAS  Google Scholar 

  9. Baskin SM. Editorial: Personality and migraine. Headache 1995; 35: 380–1

    Article  PubMed  CAS  Google Scholar 

  10. Breslau N, Merikangas KR, Bowden CL. Comorbidity of migraine and major affective disorders. Neurology 1994; 44(7 Suppl.): S17–S22

    PubMed  CAS  Google Scholar 

  11. Tennant A, McKenna SP. Conceptualising and defining outcome. Br J Rheumatol 1995; 34: 899–900

    Article  PubMed  CAS  Google Scholar 

  12. More T. Utopia. London: Chatto & Windus Publishers, 1516/1908

    Google Scholar 

  13. McClelland DC. Personality. New York: William Sloane, 1951

    Book  Google Scholar 

  14. Maslow AH. Motivation and personality. New York: Harper & Row, 1954

    Google Scholar 

  15. McCall S. Quality of life. Soc Ind Res 1975; 2: 229–48

    Google Scholar 

  16. McKenna SP, Hunt SM. A new measure of quality of life in depression: Testing the reliability and construct validity of the QLDS. Health Pol 1992; 22: 321–30

    Article  CAS  Google Scholar 

  17. Holmes SJ, McKenna SP, Doward LC, et al. Development of a questionnaire to assess the quality of life of adults with growth hormone deficiency. Endocrinol Metab 1995; 2: 63–9

    Google Scholar 

  18. McKenna SP, Doward LC. Measuring quality of life in recurrent genital herpes. Eur Rev Appl Psychol 1995; 45: 289–95

    Google Scholar 

  19. Wagner TH, Patrick DL, McKenna SP, et al. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996; 5: 443–9

    Article  PubMed  CAS  Google Scholar 

  20. de Jong Z, van der Heijde D, McKenna SP, et al. The reliability and construct validity of the RAQoL: a rheumatoid arthritis-specific quality of life instrument. Br J Rheumatol 1997; 36: 878–83

    Article  PubMed  Google Scholar 

  21. Hunt SM, McKenna SP. The QLDS: a scale for the measurement of quality of life in depression. Health Pol 1992; 22: 307–19

    Article  CAS  Google Scholar 

  22. Jenkinson C, Fitzpatrick R, Argyle M. The Nottingham Health Profile: an analysis of its sensitivity in differentiating illness groups. Soc Sci Med 1988; 27: 1411–4

    Article  PubMed  CAS  Google Scholar 

  23. McKenna SP. Quality of life assessment in the conduct of economic evaluations of medicines. Br J Med Econ 1995; 8: 33–8

    Google Scholar 

  24. Solomon GD, Skobieranda FG, Genzen JR. Quality of life assessment among migraine patients treated with sumatriptan. Headache 1995; 35: 449–54

    Article  PubMed  CAS  Google Scholar 

  25. Dahlöf CG, Dimenäs E. Migraine patients experience poorer subjective well-being/quality of life even between attacks. Cephalalgia 1995; 15: 31–6

    Article  PubMed  Google Scholar 

  26. Richard A, Henry P, Chazot G, et al. Qualité de vie et migraine: validation du questionnaire QVM en consultation hospitalière et en médecine générale. Therapie 1993; 48: 89–96

    PubMed  CAS  Google Scholar 

  27. Hartmaier SL, Santanello NC, Epstein RS, et al. Development of a brief 24-hour migraine-specific quality of life questionnaire. Headache 1995; 35: 320–9

    Article  PubMed  CAS  Google Scholar 

  28. Heinemann AW, Whiteneck GG. Relationships among impairment, disability, handicap and life satisfaction in persons with traumatic brain injury. J Head Trauma Rehabil 1995; 10: 54–63

    Article  Google Scholar 

  29. Whiteneck GG. Measuring what matters: key rehabilitation outcomes. Arch Phys Med Rehabil 1994; 75: 1073–6

    Article  PubMed  CAS  Google Scholar 

  30. Mushet GR, Miller D, Clements B, et al. Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine. Headache 1996; 36: 137–43

    Article  PubMed  CAS  Google Scholar 

  31. Jhingran P, Cady RK, Rubino J, et al. Improvements in health-related quality of life with sumatriptan treatment for migraine. J Fam Pract 1996; 42: 36–42

    PubMed  CAS  Google Scholar 

  32. Cohen JA, Beall DG, Miller DW, et al. Subcutaneous sumitriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Fam Med 1996; 28: 171–7

    PubMed  CAS  Google Scholar 

  33. Langeveld JH, Koot HM, Loonen MC, et al. A quality of life instrument for adolescents with chronic headache. Cephalalgia 1996; 16: 183–96

    Article  PubMed  CAS  Google Scholar 

  34. Wagner TH, Patrick DL, Galer BS, et al. A new instrument for the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache 1996; 36: 484–92

    Article  PubMed  CAS  Google Scholar 

  35. Cortina JM. What is coefficient alpha? An examination of theory and applications. J Appl Psychol 1993; 78: 98–104

    Article  Google Scholar 

  36. McDowell I, Newell C. Measuring health: a guide to rating scales and questionnaires. Oxford: Oxford University Press, 1987

  37. McKenna SP, Hunt SM. The General Weil-Being Index: adapting and retesting an American measure for use in the United Kingdom. Br J Med Econ 1992; 4: 41–50

    Google Scholar 

  38. Fletcher A, Gore S, Jones D, et al. Quality of life measures in health care. II: Design, analysis, and interpretation. BMJ 1992; 305: 1145–8

    Article  PubMed  CAS  Google Scholar 

  39. Linet MS, Stewart WF, Celentano DD, et al. An epidemiologic study of headache among adolescents and young adults. JAMA 1989; 261: 2211–6

    Article  PubMed  CAS  Google Scholar 

  40. Waters WE. Headache. Littleton: PSG, 1986

    Google Scholar 

  41. Lipton RB, Stewart W, Celentano DD, et al. Undiagnosed migraine: a comparison of symptom-based and self-reported physician diagnosis. Arch Intern Med 1992; 156: 1–6

    Google Scholar 

  42. Cella DF. Quality of life: concepts and definition. J Pain Symptom Manage 1994; 9(3): 186–92

    Article  PubMed  CAS  Google Scholar 

  43. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med 1993; 118: 622–9

    PubMed  CAS  Google Scholar 

  44. Mechanic D. The concept of illness behaviour. J Chronic Dis 1962; 17: 189–94

    Article  Google Scholar 

  45. Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med 1983; 303: 1038–41

    Google Scholar 

  46. Streiner D, Norman G. Health Measurement Scales. Oxford: Oxford University Press, 1989

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Galen Research, Enterprise House, Manchester Science Park, Lloyd Street North, Manchester, M15 6SE, England

    Stephen P. McKenna, Lynda C. Doward & Kate Mackenzie Davey

Authors
  1. Stephen P. McKenna
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lynda C. Doward
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kate Mackenzie Davey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Stephen P. McKenna.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McKenna, S.P., Doward, L.C. & Davey, K.M. The Development and Psychometric Properties of the MSQOL. Clin. Drug Investig. 15, 413–423 (1998). https://doi.org/10.2165/00044011-199815050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-199815050-00006

Keywords

Search

Navigation